ORAMED PHARMACEUTICALS INC. — Net Income by Fiscal Year
19 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/19f86b2d-ef26-4035-8b20-b88093b704eb/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $75.3k | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-084609 |
| FY 2024 | $-15.9k | 2024-01-01 – 2024-12-31 | evidence 0001213900-26-084609 |
| FY 2023 | $5.1k | 2023-01-01 – 2023-12-31 | evidence 0001213900-26-084609 |
| FY 2022 | $-36.6M | 2022-01-01 – 2022-12-31 | evidence 0001213900-24-020485 |
| FY 2021 | $-23.0M | 2020-09-01 – 2021-08-31 | evidence 0001213900-21-062009 |
| FY 2020 | $-11.5M | 2019-09-01 – 2020-08-31 | evidence 0001213900-20-038924 |
| FY 2019 | $-14.4M | 2018-09-01 – 2019-08-31 | evidence 0001213900-19-024940 |
| FY 2018 | $-12.7M | 2017-09-01 – 2018-08-31 | evidence 0001213900-18-016666 |
| FY 2017 | $-10.5M | 2016-09-01 – 2017-08-31 | evidence 0001213900-17-012754 |
| FY 2016 | $-11.0M | 2015-09-01 – 2016-08-31 | evidence 0001213900-16-018954 |
| FY 2015 | $-7.2M | 2014-09-01 – 2015-08-31 | evidence 0001213900-16-018954 |
| FY 2014 | $5.7M | 2013-09-01 – 2014-08-31 | evidence 0001213900-15-009096 |
| FY 2013 | $-24.4M | 2002-04-12 – 2014-02-28 | evidence 0001178913-14-001274 |
| FY 2012 | $-21.3M | 2002-04-12 – 2013-05-31 | evidence 0001178913-13-002087 |
| FY 2011 | $-16.6M | 2002-04-12 – 2012-05-31 | evidence 0001178913-12-001916 |
| FY 2010 | $-13.0M | 2002-04-12 – 2010-08-31 | evidence 0001178913-12-000118 |
| FY 2009 | $-2.8M | 2008-09-01 – 2009-08-31 | evidence 0001178913-12-003413 |
| FY 2008 | $-2.8M | 2007-09-01 – 2008-08-31 | evidence 0001178913-12-003413 |
| FY 2007 | $-4.5M | 2002-04-12 – 2007-08-31 | evidence 0001178913-12-003413 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ORAMED PHARMACEUTICALS INC. — all facts · Revenue · Operating Income